Athos Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Athos biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Athos Biopharma Today - Breaking & Trending Today

iOmx Therapeutics to present new data on lead programs and I/O target screening platform at AACR 2024

iOmx Therapeutics to present new data on lead programs and I/O target screening platform at AACR 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand General , New Zealand , San Diego , Apollon Papadimitriou , Shaun Brown , Athos Biopharma , Katja Arnold , American Association For Cancer Research , Mc Services , Omx Therapeutics , American Association , Cancer Research , Annual Meeting , Immune Checkpoints , Inhibitory Molecules , Screening Platform , Uncovering Colorectal Cancer Evasion , Sofinnova Partners , Wellington Partners ,

EQS-News: iOmx Therapeutics AG: iOmx Therapeutics attends upcoming scientific and industry conferences

EQS-News: iOmx Therapeutics AG: iOmx Therapeutics attends upcoming scientific and industry conferences
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , San Diego , New Zealand General , New Zealand , Nils Debus , Athos Biopharma , Katja Arnold , Apollon Papadimitriou , Shaun Brown , German Cancer Research Center , Society For Immunotherapy Of Cancer , Distribution Services , Mc Services , Omx Therapeutics , Annual Meeting , Immune Monitoring , Philipp Beckhove , Wellington Partners , Sofinnova Partners , Corporate News , Regulatory Announcements ,

iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer

EQS-News: iOmx Therapeutics AG / Key word(s): PersonneliOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer 05.09.2023 / 08:30 CET/CESTThe issuer is solely responsible for the content of this announcement.iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business OfficerMartinsried / Muni. ....

New Zealand General , New Zealand , United States , Nils Debus , Apollon Papadimitriou , Nils Peter Debus , Katja Arnold , Boehringer Ingelheim , Shaun Brown , Athos Biopharma , Merz Pharmaceuticals Frankfurt , Duke University Durham , German Cancer Research Center , Humboldt University Berlin , Mc Services , Business Development Licensing , Distribution Services , Omx Therapeutics , Chief Business Officer , Chief Business , Business Development , Merz Pharmaceuticals , Humboldt University , Duke University , Philipp Beckhove , Wellington Partners ,

iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg™ and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023

iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg™ and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand General , New Zealand , Athos Biopharma , Philipp Beckhove , Nisit Khandelwal , Christine Rothe , Shaun Brown , American Association For Cancer Research , Head Of Research , Mc Services Agkatja Arnold , German Cancer Research Center , Omx Therapeutics , American Association , Cancer Research , Annual Meeting , Chief Development Officer , Abstract Number , Immune Checkpoints , Tumor Beds , Therapeutic Benefit , Wellington Partners , Sofinnova Partners , Shaun Brownt ,

iOmx Therapeutics appoints Professor Frances Balkwill to the Scientific Advisory Board

iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next-generation immune checkpoint targets, today announced the appointment of Frances Balkwill, Professor of Cancer Biology at Barts Cancer Institute, Queen Mary University of London, to its Scientific Advisory Board (SAB). ....

New Zealand General , New Zealand , United Kingdom , Athos Biopharma , Philipp Beckhove , Katja Arnold , Nisit Khandelwal , Frances Balkwill , Shaun Brown , Mc Services , Professor At Barts Cancer Institute , Queen Mary University Of London , Cancer Research United Kingdom , Clinical Trials Committee , German Cancer Research Center , Omx Therapeutics , Cancer Biology , Barts Cancer Institute , Queen Mary University , Scientific Advisory Board , Senior Vice President Research , Deputy Lead , Tumour Microenvironment , Blood Cancer United Kingdom , Research Advisory Committee , Prostate Cancer United ,